World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
137
Citations
169280
World Ranking
1848
National Ranking
51

Faiez Zannad publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Faiez Zannad sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 950 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Faiez Zannad D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Faiez Zannad sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 137 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Faiez Zannad is affiliated with the University of Lorraine in France, where they focus primarily on medical research. Their body of work spans several key fields, emphasizing cardiology and cardiovascular medicine as the dominant area of study.

Their research covers diverse subfields, including:

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

The main topics addressed in their scientific contributions include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Hormonal Regulation and Hypertension
  • Pancreatic Function and Diabetes
  • Cardiac Pacing and Defibrillation Studies
  • Potassium and Related Disorders

Faiez Zannad has authored several recent papers, notable for their presence in high-impact journals:

  • "SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials," 2020, The Lancet
  • "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure," 2020, New England Journal of Medicine
  • "Empagliflozin in Heart Failure with a Preserved Ejection Fraction," 2021, New England Journal of Medicine
  • "Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials," 2022, The Lancet
  • "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure," 2020, New England Journal of Medicine

Among frequent co-authors collaborating with Faiez Zannad are:

  • João Pedro Ferreira
  • John J.V. McMurray
  • Milton Packer
  • Nicolas Girerd
  • Gerasimos Filippatos

Their research findings have been published repeatedly in key academic venues:

  • European Journal of Heart Failure
  • Journal of the American College of Cardiology
  • European Heart Journal
  • Circulation
  • JACC Heart Failure

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

    Bertram Pitt;Faiez Zannad;Willem J. Remme;Robert Cody

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

    Bertram Pitt;Willem Remme;Faiez Zannad;James Neaton

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Haidong Wang;Mohsen Naghavi;Christine Allen;Ryan M Barber

  • The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

    Bertram Pitt;Faiez Zannad;Willem J. Remme;Robert Cody

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

    G Mancia;EA Rosei;R Cifkova;G DeBacker

  • Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

    Faiez Zannad;John J. V. McMurray;Henry Krum;Dirk J. van Veldhuisen

  • Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    William B. White;Christopher P. Cannon;Simon R. Heller;Steven E. Nissen

  • Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

    Christopher M. O'Connor;David J. Whellan;David J. Whellan;Kerry L. Lee;Steven J. Keteyian

  • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

    Bengt C. Fellström;Alan G. Jardine;Roland E. Schmieder;Hallvard Holdaas

  • Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.

    P.-J. Touboul;M.G. Hennerici;S. Meairs;H. Adams

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redán

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

    Joep Perk;Guy De Backer;Helmut Gohlke;Ian Graham

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

Frequent Co-Authors

Bertram Pitt
Bertram Pitt University of Michigan–Ann Arbor
Mihai Gheorghiade
Mihai Gheorghiade Northwestern University
John J.V. McMurray
John J.V. McMurray University of Glasgow
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
John G.F. Cleland
John G.F. Cleland University of Glasgow
Kenneth Dickstein
Kenneth Dickstein University of Bergen
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Karl Swedberg
Karl Swedberg University of Gothenburg
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse and rewarding opportunities. For those interested in health leadership, a health care administration degree online provides flexible study options. This degree prepares graduates to manage healthcare facilities, lead teams, and navigate complex regulations.

Nurses looking to advance can fast-track their careers through adn to fnp programs. These programs support registered nurses in earning advanced family nurse practitioner credentials, meeting the growing healthcare needs in the U.S.

For those passionate about wellness, an online degree nutrition offers a path to roles in dietetics, health education, and nutritional research. Graduates may work in healthcare, industry, or community organizations promoting better health.

If your goal is to step into executive roles, consider cahme accredited mha online programs. These programs ensure quality training in healthcare administration and are recognized by employers nationwide.

Best Scientists Citing Faiez Zannad

Trending Scientists

Recently Published Articles